ASN
INM icon

Advisory Services Network’s InMed Pharmaceuticals INM Stock Holding History

Advisory Services Network’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$25 – 2537
2023
Q4 		$25 Buy
+3
New +$29 ﹤0.01% 3830
2023
Q2 		– Hold
0
– -$6 – 2514
2023
Q1 		– Hold
0
– – – 3976
2022
Q4 		– Hold
0
– – – 3978
2021
Q3 		– Hold
0
– – – 2313
2021
Q2 		– Hold
0
– – – 3620
2021
Q1 		– Hold
0
– – – 2127
2020
Q4 		– Hold
0
– – – 3488

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Services Network's INM Position: Q1 2024 in Review

Advisory Services Network sold out of InMed Pharmaceuticals (INM) in Q1 2024, closing a stake of 3 shares — an estimated $25 sold.

Advisory Services Network first reported a position in INM in Q4 2023 and held it in 1 quarter. The position peaked at $25 in Q4 2023. 15 funds tracked by Wall St. Rank hold INM as of Q1 2024.

  • Advisory Services Network reported no remaining InMed Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 3 InMed Pharmaceuticals shares in Q1 2024, an estimated $25.
  • Advisory Services Network first reported a position in InMed Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Advisory Services Network's InMed Pharmaceuticals position peaked at $25 in Q4 2023.
  • 15 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.